Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children. 1981

R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani

The metabolism and elimination of chloramphenicol-3-monosuccinate was studied in 45 infants and children, ages 3 days to 16 years, during intravenous administration. The apparent half-life of chloramphenicol was extremely variable, ranging from 1.7 to 12.0 hours with a mean of 5.1 hours. Apparent half-lives were inversely correlated with age. Chloramphenicol-S serum concentration declined biexponentially in most patients, with an estimated mean initial half-life of 0.7 hours and a subsequent longer mean half-life of 2.2 hours. Chloramphenicol-S persisted in serum up to six hours after a dose, and comprised a significantly larger fraction of total chloramphenicol in the serum of infants under one month of age than in older infants and children. A widely variable fraction of the administered chloramphenicol-S dose, with a mean of 33%, was excreted in the urine unchanged and was, therefore, not bioavailable in active form. Mean renal clearance of chloramphenicol-S was 259.5 ml/minute/1.73 M2, four times the mean creatinine clearance, indicating active tubular secretion. Variable hydrolysis and renal elimination of nonhydrolyzed chloramphenicol-S reduces the bioavailability of the antibiotic and appears to contribute substantially to the wide variation in apparent half-life and poor correlation between dose and serum concentration of free chloramphenicol.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
January 1982, Pediatric pharmacology (New York, N.Y.),
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
January 1984, Clinical pharmacokinetics,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
October 1980, Pediatrics,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
January 1983, Developmental pharmacology and therapeutics,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
December 1981, The Journal of pediatrics,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
January 1983, Journal of clinical pharmacology,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
November 1981, The Journal of pharmacology and experimental therapeutics,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
January 1957, Antibiotics annual,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
October 2013, Journal of veterinary pharmacology and therapeutics,
R E Kauffman, and J N Miceli, and L Strebel, and J A Buckley, and A K Done, and A S Dajani
April 1985, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
Copied contents to your clipboard!